A Case of a Male Patient with Frontotemporal Dementia with Behavioral and Psychological Symptoms Responding to a Low Dose of Escitalopram

Author(s):  
Atsuko Ikenouchi ◽  
Issei Seki ◽  
Kei Takaoka ◽  
Sayuri Murakami ◽  
Naomichi Okamoto ◽  
...  

Abstract Background: Frontotemporal dementia (FTD) is a common type of early-onset dementia. It is characterized by insidious onset and gradual progression, early decline in social interpersonal conduct and regulation of personal conduct, early emotional blunting and loss of insight. Behavioral disorder, speech and language are supportive features in FTD. Here, we present a case of a patient with FTD with behavioral and psychological symptoms of dementia (BPSD) responding to escitalopram treatment.Case presentation: A 60-year-old Japanese man had been treated for early-onset Alzheimer-type dementia with galantamine (24 mg/day) for 5 years. He developed behavioral, executive and semantic deficits. He had stereotypical, compulsive behavior, eating habit changes, disinhibition, excitement, irritability and anxiety. His diagnosis changed to FTD based on clinical features and MRI and SPECT. Galantamine was tapered off, and escitalopram 5 mg/day was started and increased to 10 mg/day. The symptoms of FTD, including behavioral and psychological symptoms, were decreased.Conclusion: This case is the first report demonstrating that escitalopram might be effective for BPSD that accompany FTD.


2020 ◽  
Vol 40 (1) ◽  
pp. 10-15 ◽  
Author(s):  
Yuya Takahashi ◽  
Sho Shindo ◽  
Takashi Kanbayashi ◽  
Masahiro Takeshima ◽  
Aya Imanishi ◽  
...  


2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Zhanjie Zheng ◽  
Jindong Wang ◽  
Lei Yi ◽  
Hui Yu ◽  
Lingli Kong ◽  
...  

The relationship between plasma homocysteine and behavioral and psychological symptoms of dementia (BPSD) has not been specifically investigated in previous research. In this study, we compared plasma homocysteine (Hcy) among 40 Alzheimer’s disease (AD) patients with BPSD, 37 AD patients without BPSD, and 39 healthy controls. Our results evidenced that the plasma homocysteine levels in AD patients with BPSD and without BPSD were higher than healthy controls and that the plasma homocysteine concentration in AD patients with BPSD was the highest among the three groups. Significant correlation between plasma homocysteine concentration and cognitive decline and duration of dementia was observed, but there was no correlation between BPSD and cognitive dysfunction or duration of dementia. In conclusion, this study showed for the first time that BPSD were associated with plasma homocysteine concentration in Alzheimer's dementia, and the results supported that hyperhomocysteine may take part in the pathogenesis of BPSD.



2014 ◽  
Vol 10 ◽  
pp. P287-P288
Author(s):  
Femke Bouwman ◽  
Pieter Jelle Visser ◽  
Charlotte Teunissen ◽  
Mike Wattjes ◽  
Philip Scheltens ◽  
...  


Author(s):  
Martina Bocchetta ◽  
Jonathan D Rohrer

The term frontotemporal dementia (FTD) describes a heterogeneous group of neurodegenerative disorders with multiple genetic and pathological causes. However, there is sufficient overlap both clinically, in terms of behavioural and/or language difficulties, and anatomically, with neuronal loss occurring in the frontal and temporal lobes, that the conditions are commonly considered together as one group. Overall, the FTD disorders represent a common cause of early-onset dementia, approximately equal in frequency to Alzheimer’s disease in people under the age of 65. The only known risk factors are genetic, and about a third of cases are due to an autosomal dominant mutation. No curative treatment is currently available and symptomatic and supportive care is the mainstay of management. This chapter discusses the concept of FTD, describing its clinical presentation, genetics, neuropathology, neuroimaging, fluid biomarkers, and management.





2012 ◽  
Vol 20 (9) ◽  
pp. 789-797 ◽  
Author(s):  
Nathan Herrmann ◽  
Sandra E. Black ◽  
Tiffany Chow ◽  
Jaclyn Cappell ◽  
David F. Tang-Wai ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document